However, the present drugs (e.g., tacrine, galantamine, donepezil and rivastigmine) (Figure 1) with AChE inhibitory activity possess some side effects and are effective only against the mild type of AD, and currently there is no drug with BuChE inhibitory activity available [9,10]. This evidence concerns the gene ACHE and Alzheimer disease.